Related Experiment Video
Updated: Oct 2, 2025
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
Biliary Atresia: A Complex Hepatobiliary Disease with Variable Gene Involvement, Diagnostic Procedures, and Prognosis
Consolato M Sergi1,2, Susan Gilmour3
1Stollery Children's Hospital, Laboratory Medicine and Pathology, University Alberta Hospital, University of Alberta, Edmonton, AB T6G 2B7, Canada.
Insights
Biliary atresia diagnosis remains challenging. Research is shifting focus from viruses to genetics, investigating genes like ADD3 and GPC1, to find a curative treatment for this infant liver disease.
Area of Science:
- Hepatology
- Neonatal Medicine
- Genetics
Background:
- Biliary atresia diagnosis presents a significant challenge in neonatal intensive care units.
- The etiology of this obstructive cholangio-hepatopathy remains largely ambiguous despite systematic evaluation.
- Recurrent cases within families suggest a potential genetic component.
Purpose of the Study:
- To review the complexities of biliary atresia, an infant liver disease.
- To highlight the shift in research interest from viral causes to genetic factors.
- To explore the potential for identifying the etiology and developing curative treatments.
Main Methods:
- Review of existing literature on biliary atresia.
- Investigation into familial recurrence at a molecular level.
- Analysis of genetic factors, including specific gene studies (e.g., ADD3, GPC1).
Main Results:
- The etiology of biliary atresia is still not fully understood.
- Genetic factors, such as mutations in ADD3 and GPC1, are increasingly implicated.
- The role of genetic syndromes in biliary atresia development warrants further investigation.
Conclusions:
- Understanding the genetic underpinnings of biliary atresia is crucial for developing curative strategies.
- Further research into genes like ADD3 and GPC1 may unlock new diagnostic and therapeutic avenues.
- Shifting focus to genetics offers hope for moving beyond symptomatic treatment to a cure for infant liver disease.
Abstract:
The diagnosis of biliary atresia is still terrifying at the 3rd decade of the 21st century. In a department of neonatal intensive care unit, parents and physicians face a challenge with a jaundiced baby, who may or may not have a surgically correctable hepatopathy. The approach has been systematically evaluated, but the etiology remains ambiguous. The study of families with recurrent biliary atresia has been undertaken at a molecular level. The primary interest with this disease is to identify the etiology and change the treatment from symptomatic to curative. The occurrence of this obstructive cholangio-hepatopathy in well-known genetic syndromes has suggested just coincidental finding, but the reality can be more intriguing because some of these diseases may have some interaction with the development of the intrahepatic biliary system. Several genes have been investigated thoroughly, including ADD3 and GPC1 shifting the interest from viruses to genetics. In this review, the intriguing complexities of this hepatobiliary disease are highlighted.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:35Pedigree Analysis
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:16Hepatic Drug Excretion: Influencing Factors